MedPath

广东元宁制药有限公司

Ownership
-
Established
2012-02-15
Employees
-
Market Cap
-
Website
http://www.yuanningzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Rifampin and Isoniazid Capsules

Product Name
异福胶囊
Approval Number
国药准字H44025396
Approval Date
Apr 16, 2020
NMPA

Metronidazole Vaginale Effervescent Tablets

Product Name
甲硝唑阴道泡腾片
Approval Number
国药准字H20003388
Approval Date
Apr 7, 2020
NMPA

小儿咳喘灵颗粒

Approval Number
国药准字Z44021041
Approval Date
Apr 7, 2020
NMPA

Nizatidine Capsules

Product Name
尼扎替丁胶囊
Approval Number
国药准字H20059748
Approval Date
Apr 7, 2020
NMPA

Isoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H44022151
Approval Date
Apr 7, 2020
NMPA

复方丹参片

Approval Number
国药准字Z44021032
Approval Date
Apr 2, 2020
NMPA

脑血栓片

Approval Number
国药准字Z44021038
Approval Date
Apr 1, 2020
NMPA

灯盏花素片

Approval Number
国药准字Z44021031
Approval Date
Apr 1, 2020
NMPA

Alginic Sodium Diester Tablets

Product Name
藻酸双酯钠片
Approval Number
国药准字H44022152
Approval Date
Apr 1, 2020
NMPA

石淋通颗粒

Approval Number
国药准字Z19993239
Approval Date
Mar 11, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.